The immunogenic potential of the medulloblastoma specific EPC2–GULP1 fusion peptide was tested on CD8+ T cells from three healthy donors with HLA-A*02:01 specification towards the IFN-γ secretion. This evidence concerns the gene IFNG and medulloblastoma.